Risk of Pulmonary and Venous Thromboembolism in Pregnancies After in Vitro Fertilization

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

140458 participants

Study Classification

OBSERVATIONAL

Study Start Date

1990-01-31

Study Completion Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Occurrence of venous thromboembolism during in Vitro Fertilization (IVF) pregnancies has been reported in numerous case reports and in two small consecutive series. The incidence of venous thromboembolism (VTE) after IVF has been claimed to be comparable to the incidence of VTE during normal pregnancy. No information exists concerning pulmonary embolism (PE).

The aim is to estimate and compare the risk of both PE and VTE during the the different phases of pregnancy after IVF to that in age and period matched control women. The investigators will use the Swedish National Health Registers to estimate the risk.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Incidence of Pulmonary and Venous Thromboembolism in IVF Pregnancies After Fresh and Frozen Embryo Transfer

NCT03660007

Assisted Reproductive Techniques Pregnancy Pulmonary Embolism +3 more

COMPLETED

Endometrial Local Injury Before First IVF : Evaluation of Pregnancy Rate

NCT02522806

Sterility, Female

COMPLETED NA

Influence of Environmental Conditions on In Vitro Fertilization (IVF) Attempts and Induced Pregnancies

NCT02236780

In Vitro Fertilisation Environmental Conditions

UNKNOWN

Retrospective Database Studies

NCT01219296

All Patients Undergoing Infertility Treatment

COMPLETED

Immediate Versus Postponed Single Blastocyst Transfer in Programmed or Stimulated Cycle Frozen Embryo Transfer

NCT06304792

Infertility IVF

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background: Occurrence of venous thromboembolism (VTE) during IVF pregnancies has been reported in numerous case reports and in two small consecutive series. The incidence of VTE after IVF has been claimed to be comparable to the incidence of VTE during normal pregnancy. No information exists concerning pulmonary embolism (PE).

Aim: The aim is to estimate and compare the risk of both PE and VTE during the trimesters of pregnancy after IVF to that in age and period matched control women.

Design and methods: A cross-sectional study using linkage of Swedish population and health registers. The Swedish National Patient Register encompasses inpatients and outpatients. Inpatient data in Sweden is available nationwide since 1987. Outpatient diagnoses from hospitals started to be collected in 1997. Data in the Patient Register will be linked to the Swedish Medical Birth Register (MBR) at the National Board of Health and Welfare through the unique personal identity number assigned to all Swedish residents, Exposed women: Mothers who had given birth to a child as a result of IVF will be retrieved from the Swedish IVF Register at the National Board of Health and Welfare. The Swedish IVF Register is now a part of the Swedish Medical Birth Register (MBR) at the National Board of Health and Welfare and includes information on IVF pregnancies since 1982.

We will restrict the retrieval to mothers of a child born as from 1990 until 2008 and who had their first child born after assisted reproduction by IVF.

Unexposed women: Each IVF woman will be matched with 5 unexposed women from the MBR by calendar year of delivery and maternal age.

Information will be retrieved on country of birth, pre-pregnancy body mass index, family situation, cigarette smoking habits, number of older siblings, singleton/multiple births, and estimated length of gestation from the MBR register. Dates of the trimesters is calculated from the length of gestation. Women´s education is found in the Register of Education, Statistics Sweden, by linkage through the personal identity number.

Diagnoses of VTE including PE will be found by linkage to the Swedish Patient Register of the National Board of Health and Welfare. This register comprises date of admission and discharge, and main diagnosis with up to seven contributing diagnoses. Diagnoses are recorded according to the International Classification of Diagnoses (ICD), ninth version prior to 1996 and the tenth version from 1997. Codes used were 415B, 451B, 452, 453C-D, 453W, 453X, 673C, 671D-E, 671F in ICD9 and I260, I269, I801- 3, I808-9, I822-3, I828-9, O223, O225, O871, O873, O879, O882 in ICD10.

The study is approved by the Research Ethics Committee of Karolinska Institutet, Stockholm, Sweden (Dnr 2010/267-31/4).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Embolism Venous Thromboembolism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

IVF pregnancy

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Exposed women:

* All mothers who had given birth to a child as a result of IVF will be retrieved from the Swedish Medical Birth Register (MBR) at the National Board of Health and Welfare.

Unexposed women:

* Each IVF woman will be matched with up to 5 unexposed women from the MBR by calendar year of delivery ±2 years and maternal age ±1 year.

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No